Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30232 |
AWD 12-281
GSK 842470,GSK-842470,AWD12-281,AWD-12-281,GW 842470 |
PDE | Metabolism |
AWD 12-281 是一种选择性磷酸二酯酶 4 (PDE4) 抑制剂,具有抗炎活性和支气管扩张活性,用于研究慢性阻塞性肺疾病(COPD)。 | |||
T26694 |
AWD12−281
AWD 12281,AWD12281,AWD 12−281,AWD-12−281,AWD-12281 |
||
AWD12−281 is an inhibitor of PDE4. | |||
T69614 |
Ethybenztropine HBr
|
||
Ethybenztropine HBr is an anticholinergic which is used as an antiparkinsonian agent. Ethybenztropine may also act as a dopamine reuptake inhibitor. | |||
T69615 |
AWD12-281 sodium
|
||
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of lung inflammation using inhalative administration. AWD 12-281 Is Active in a New Guinea-Pig Model of Allergic Skin Inflammation Predictive of Human Skin Penetration and Suppresses Both Th1 and Th2 Cytokines in Mice. AWD 12-281 is a very promising drug candidate not only for the treatment of lung inflammation using inhalative administration but also for the treatment of atopic dermatitis. |